Search | IOVS | ARVO Journals

Showing 1 – 20 of 46

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Utility of Assessment of Suspected Inherited Retinal Dystrophies with a Broad Genetic Screening Panel

Richard Polo; Konstatin Astafurov; Jonathan Prenner; Howard Fine

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1528.

ARVO Annual Meeting Abstract June 2021

Long-term outcomes of a surgical technique for scleral suture fixation of a posteriorly dislocated lens-bag complex without conjunctival opening (Hoffman pockets)

Konstantin Astafurov; Jonathan Prenner; Howard Fine; Matthew Wheatley

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3668.

ARVO Annual Meeting Abstract June 2020

Effect of Pars Plana Vitrectomy (PPV) on the Treatment Interval of Intravitreal Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Agents

Rui Zhang; Yan Zhu; Alex Y Kim; Sairamya Bodempudi; Howard F Fine; Daniel B Roth; H. Matthew Wheatley; Jonathan L Prenner; Dimosthenis Mantopoulos

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4389.

ARVO Annual Meeting Abstract June 2017

Office-based t-PA assisted pneumatic displacement of submacular hemorrhage secondary to neovascular age-related macular degeneration (ARMD): A comparative study of newly-converted, treatment-naïve eyes vs. eyes with anti-VEGF therapy prior to presentation.

Santosh P Bhaskarabhatla; Howard F Fine; Dimosthenis Mantopoulos; Daniel B. Roth; Nicholas Chinskey; Sumit P. Shah

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1928.

ARVO Annual Meeting Abstract June 2017

Postoperative sterile inflammation after pars plana vitrectomy with indocyanine green

Dimosthenis Mantopoulos; Jimmy Patel; Jonathan Prenner; Sumit P. Shah; Nicholas Chinskey; Daniel B. Roth; Howard F Fine

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5023.

ARVO Annual Meeting Abstract June 2017

One-Year Follow Up Results of Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema (DME) in Highly Treated Eyes

Nisha Dhawlikar; Sumit P. Shah; David L. Yarian; Jonathan Prenner; Eric S. Friedman; H. Matthew Wheatley; Howard F Fine; Dimosthenis Mantopoulos; Daniel B. Roth

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):914.

ARVO Annual Meeting Abstract September 2016

Real-World Assessment of Dexamethasone Intravitreal Implant in Diabetic Macular Edema: Interim Analysis from the REINFORCE Study

Howard F Fine; Michael Singer; Pravin U Dugel; Antonio Capone, Jr.; John Maltman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3259.

ARVO Annual Meeting Abstract September 2016

Retina specialists treating cystoid macular edema secondary to retinal vein occlusion recommend different treatments for patients than they would choose for themselves

Marlene D Wang; Sumit P Shah; Karen W Jeng; Henry Feng; Howard F. Fine; Jonathan L. Prenner

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4161.

ARVO Annual Meeting Abstract September 2016

Short Term Results of Fluocinolone Acetonide Intravitreal Implant (Iluvien®) for Diabetic Macular Edema in Highly Treated Eyes

Nisha Dhawlikar; Sumit P Shah; David L. Yarian; Jonathan L. Prenner; Eric S. Friedman; Howard F. Fine; H. Matthew Wheatley; Daniel B Roth

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3240.

ARVO Annual Meeting Abstract June 2015

Assessing Intraocular Inflammation After Ranibizumab and Aflibercept Injections for Neovascular AMD

Daniel B Roth; Howard F Fine; jonathan prenner; Sumit P Shah; Henry Feng

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1520.

ARVO Annual Meeting Abstract June 2015

Aflibercept (Eylea®) for Refractory Diabetic Macular Edema

Karen W Jeng; Greg Budoff; Howard F Fine; Daniel B Roth; jonathan prenner

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1760.

ARVO Annual Meeting Abstract June 2015

Clinical findings in triamcinolone associated maculopathy

Edith Reshef; Howard F Fine; jonathan prenner; Sumit P Shah; Daniel B Roth; Hans E Grossniklaus

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2035.

ARVO Annual Meeting Abstract April 2014

Postmarketing Surveillance Survey of Adverse Events of Ocriplasmin (Jetrea®)

Sumit P Shah; Karen Jeng; Howard F Fine; Harold M Wheatley; Daniel B Roth

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2208.

ARVO Annual Meeting Abstract April 2014

Predictors of Success with Intravitreal Ocriplasmin in the Treatment of Symptomatic Vitreomacular Adhesion

Daniel B Roth; Henry L Feng; Kunjal K Modi; Howard F Fine; Harold M Wheatley

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):298.

ARVO Annual Meeting Abstract April 2014

Complications of Intravitreal Ocriplasmin in the Treatment of Symptomatic Vitreomacular Adhesion

Henry L Feng; Daniel B Roth; Kunjal K Modi; Howard F Fine; Harold M Wheatley

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):308.

ARVO Annual Meeting Abstract April 2014

Prospective study on antimicrobial resistance rates following repeated courses of topical antibiotics for intravitreal injection

Tahia Haque; Thomas Kirn; Daniel B Roth; Sumit P Shah; David L Yarian; Howard F Fine

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3851.

ARVO Annual Meeting Abstract April 2014

Intraocular Inflammation Following Aflibercept (Eylea) Injection

Howard F Fine; Daniel B Roth; Sumit P Shah; Tahia Haque; Harold M Wheatley

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3855.

ARVO Annual Meeting Abstract June 2013

The Incidence of Noninfectious Intraocular Inflammation after Intravitreal Aflibercept Injection

Kunjal Modi; Daniel Roth; Howard Fine; Harold Wheatley; Jonathan Prenner; Stuart Green; David Yarian

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1104.

ARVO Annual Meeting Abstract March 2012

Perfused but not leaking

David A. Salz; Gary Shienbaum; Jonathan Prenner; Howard Fine; Richard Kaiser

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2953.

ARVO Annual Meeting Abstract March 2012

Novel Methods to Enhance Reading Ability in Patients with Macular Disease

Anthony Fernandes; Daniel Roth; Ankit Shah; Howard Fine; Jonathan Prenner; William Feuer

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6527.

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Specify Date Range

Utility of Assessment of Suspected Inherited Retinal Dystrophies with a Broad Genetic Screening Panel

Long-term outcomes of a surgical technique for scleral suture fixation of a posteriorly dislocated lens-bag complex without conjunctival opening (Hoffman pockets)

Effect of Pars Plana Vitrectomy (PPV) on the Treatment Interval of Intravitreal Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Agents

Office-based t-PA assisted pneumatic displacement of submacular hemorrhage secondary to neovascular age-related macular degeneration (ARMD): A comparative study of newly-converted, treatment-naïve eyes vs. eyes with anti-VEGF therapy prior to presentation.

Postoperative sterile inflammation after pars plana vitrectomy with indocyanine green

One-Year Follow Up Results of Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema (DME) in Highly Treated Eyes

Real-World Assessment of Dexamethasone Intravitreal Implant in Diabetic Macular Edema: Interim Analysis from the REINFORCE Study

Retina specialists treating cystoid macular edema secondary to retinal vein occlusion recommend different treatments for patients than they would choose for themselves

Short Term Results of Fluocinolone Acetonide Intravitreal Implant (Iluvien®) for Diabetic Macular Edema in Highly Treated Eyes

Assessing Intraocular Inflammation After Ranibizumab and Aflibercept Injections for Neovascular AMD

Aflibercept (Eylea®) for Refractory Diabetic Macular Edema

Clinical findings in triamcinolone associated maculopathy

Postmarketing Surveillance Survey of Adverse Events of Ocriplasmin (Jetrea®)

Predictors of Success with Intravitreal Ocriplasmin in the Treatment of Symptomatic Vitreomacular Adhesion

Complications of Intravitreal Ocriplasmin in the Treatment of Symptomatic Vitreomacular Adhesion

Prospective study on antimicrobial resistance rates following repeated courses of topical antibiotics for intravitreal injection

Intraocular Inflammation Following Aflibercept (Eylea) Injection

The Incidence of Noninfectious Intraocular Inflammation after Intravitreal Aflibercept Injection

Perfused but not leaking

Novel Methods to Enhance Reading Ability in Patients with Macular Disease

To View More...

You must be signed into an individual account to use this feature.